Key result
Annualized multidimensional adiposity gain linked to ~4% higher CVD risk per SD.
Why the study?
Cardiovascular risk associated with longitudinal adiposity change may not be fully captured by body mass index alone, motivating an evaluation of whether multidimensional anthropometric adiposity change and newly recorded dysfunction are associated with incident CVD.
Does greater longitudinal annualized change in a multidimensional anthropometric adiposity index and newly recorded organ dysfunction increase the risk of incident cardiovascular disease in middle-aged to older adults without prior CVD?
Cohort (n=49,742)
Yes
Does greater longitudinal annualized change in a multidimensional anthropometric adiposity index and newly recorded organ dysfunction increase the risk of incident cardiovascular disease in middle-aged to older adults without prior CVD?
Longitudinal increases in a multidimensional anthropometric adiposity index are modestly associated with higher subsequent cardiovascular disease risk, though this composite index offers minimal incremental predictive discrimination beyond longitudinal BMI change alone.
Answers are grounded in this paper and cite their sources.
Modest observational association warrants no change in CVD risk assessment; leaves open whether multidimensional index improves prediction beyond BMI.
Background Cardiovascular risk associated with longitudinal adiposity change may not be fully captured by body mass index. We examined whether change in multidimensional anthropometric adiposity and newly recorded dysfunction were associated with incident cardiovascular disease (CVD). Methods We analyzed 49,742 UK Biobank participants with anthropometric measurements at baseline and the first imaging assessment. A multidimensional adiposity index was constructed from body mass index, waist circumference, waist-to-hip ratio, and waist-to-height ratio. The primary exposure was annualized change in this index. Newly recorded low-overlap dysfunction was assessed separately. Cox proportional hazards models estimated associations with incident CVD. Results During a median follow-up of 4.11 years, 1,971 CVD events occurred. Greater annualized adiposity change was modestly associated with higher CVD risk in the primary adjusted model (HR per 1-SD increase, 1.045; 95% CI, 1.002–1.090; P = 0.0407). In exploratory analyses, higher CVD risk estimates were observed among participants with newly recorded dysfunction only (HR, 1.306; 95% CI, 1.014–1.682) and those with both anthropometric worsening and newly recorded dysfunction (HR, 1.550; 95% CI, 1.051–2.285). Conclusions Greater long-term multidimensional adiposity change was associated with higher subsequent CVD risk. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2026) conducted a cohort in Adiposity change and cardiovascular disease risk (n=49,742). Annualized change in a multidimensional anthropometric adiposity index (per 1-SD increase) vs. Lower annualized adiposity change / reference group with neither anthropometric worsening nor newly recorded low-overlap dysfunction was evaluated on Incident cardiovascular disease (composite of earliest occurrence of ischemic heart disease, heart failure, or stroke) (HR 1.045 per 1-SD increase, 95% CI 1.002-1.090, p=0.0407). Greater annualized multidimensional adiposity change was modestly associated with higher incident cardiovascular disease risk.
Synapse has enriched 10 related papers. Consider them for comparative context: